Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Parkinson's Disease
100%
Dystonia
76%
Leucine-rich Repeat Kinase 2 (LRRK2)
35%
Myoclonus-dystonia
29%
Multiplex
27%
Genetic Screen
24%
Primary Dystonia
22%
Cervical Dystonia
22%
Laryngeal Dystonia
22%
LOD Score
22%
Gene mutation
19%
Meta-analysis
17%
Imaging Studies
17%
Diffusion-weighted Imaging
17%
New Risks
17%
Neuropathology
17%
Gene-gene Interaction
17%
Mouse Protection Assay
17%
Wilson Disease
17%
Cardiovascular Reflexes
17%
Task-specific Dystonia
17%
Voxel-based Morphometry
17%
Risk Loci
17%
Genome-wide Association Data
17%
Substantia Nigra
17%
Sarcoglycan
17%
Disease-causing mutations
17%
Long-term Treatment
17%
Wrist Movement
17%
Botulinum Neurotoxin (BoNT)
17%
Neural Correlates
17%
R1441C
17%
Low Immunogenicity
17%
Cortical Excitability
17%
Muscle Activity
17%
Excitability
17%
North America
17%
Ballistic
17%
G2019S
17%
Sensory Discrimination
17%
Parkinson
17%
Susceptibility Genes
17%
Parkin mutation
17%
Agonist muscle
17%
Genetic Linkage Analysis
17%
Levodopa/carbidopa
17%
Parkinson Patients
16%
Sibling Pairs
15%
Parkin Gene
15%
Gray Matter
13%
Neuroscience
Parkinson's Disease
88%
Dystonia
70%
Myoclonus
29%
Parkin
23%
Spasmodic dysphonia
19%
Central Nervous System
17%
Excitability
17%
Gene Mutation
17%
Diffusion MRI
17%
Gene Interaction
17%
Cardiovascular Reflex
17%
Voxel-Based Morphometry
17%
Sarcoglycan
17%
Carbidopa/Levodopa
13%
Substantia nigra
13%
Chromosome 2
9%
X Chromosome
9%
Agonist
8%
Familial Parkinson's Disease
8%
Cardiovascular Physiology
8%
Cerebellum
8%
Gray Matter
7%
Stereotypic Movement Disorder
7%
Putamen
7%
Sensorimotor Cortex
6%
Primary Motor Cortex
5%
